Nebulised hypertonic saline (3%) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial

BMC Pediatrics

Volumn 15, Issue 1, 2015, Pages

  Khanal, Aayush ^a   Sharma, Arun ^a   Basnet, Srijana ^a   Sharma, Pushpa Raj ^a,b   Gami, Fakir Chandra ^a  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

^b KATHMANDU MEDICAL COLLEGE TEACHING HOSPITAL   (Nepal)

Author keywords

Bronchiolitis; Clinical severity score; Epinephrine; Hypertonic saline

Indexed keywords

ADRENALIN; SODIUM CHLORIDE; BRONCHODILATING AGENT; EPINEPHRINE;

ARTICLE; BRONCHIOLITIS; CHILD; CHILD HOSPITALIZATION; CLINICAL SEVERITY SCORE; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMERGENCY CARE; FEMALE; HEALTH STATUS; HEART RATE; HOSPITAL DISCHARGE; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT DURATION; TREMOR; WHEEZING; BRONCHIOLITIS, VIRAL; COMBINATION DRUG THERAPY; HOSPITAL EMERGENCY SERVICE; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EMERGENCY SERVICE, HOSPITAL; EPINEPHRINE; FEMALE; HUMANS; INFANT; MALE; NEBULIZERS AND VAPORIZERS; SALINE SOLUTION, HYPERTONIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84941216519     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-015-0434-4     Document Type: Article

References (30)

1. Chaudhary K, Sinert R. Is nebulized hypertonic saline solution an effective treatment for bronchiolitis in infants? Ann Emerg Med. 2010;55:120-2.
2. Igor R, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under 5 years of age. Bull World Health Organ. 2004;82:895-903.
3. Weber MW, Mulholland EK, Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health. 1998;3(4):268-80.
4. Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010;125:342-9.
5. Behrendt CE, Decker MD, Burch DJ,Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr. 1998;157(3):215-20.
6. Christakis DA, Cowan CA, Garrison MM,Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics. 2005;115(4):878-84.
7. Willson DF, Horn SD, Hendley JO,Smout R, Gassaway J. Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics. 2001;108(4):851-5.
8. Anil AB, Anil M, Saglam AB,Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol. 2010;45:41-7.
9. Wainwright C. Acute Viral Bronchiolitis in children- a very common condition with few therapeutic options. Paediatr Respir Rev. 2010;11:39-45.
10. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Syst Rev. 2013, Issue 7. Art. No.: CD006458. doi: 10.1002/14651858.CD006458.pub3 .
11. Al-Ansari K, Sakran M, Davidson BL,El Sayyed R, Mahjoub H, Ibrahim K. Nebulised 5 or 3 or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr. 2010;157:630-4.
12. Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol. 2010;45:36-40.
13. Giudice M, Saitta F, Leonardi S. Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis. Int J Immunopathol Pharmacol. 2012;25(2):485-91.
14. Kuzik BA, Al Qadhi SA, Kent S. Nebulised hypertonic saline in the treatment of viral bronchiolitis 1 in infants. J Pediatr. 2007;151:266-70.
15. Luo Z, Fu Z, Liu E. A randomized controlled trial of nebulised hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis. J Clin Microbiol Inf. 2011;17(12):1829-33.
16. Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X, et al. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int. 2010;52(2):199-202.
17. Mandelberg A, Tal G, Witzling M,Someck E, Houri S, Balin A, et al. Nebulised 3% hypertonic saline solution treatment for hospitalized infants with bronchiolitis. Chest. 2003;123:483-7.
18. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al. Nebulised 3% hypertonic saline solution for treatment of ambulatory children with viral bronchiolitis decreases symptoms. Chest. 2002;122:2015-20.
19. Tal G, Cesar K, Oron A. Hypertonic saline/ epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. IMAJ. 2006;8:169-73.
20. Ipek IO, Yalchin EU, Sezer RG,Bozaykut A. The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitis. Pulm Pharmacol Ther. 2011;24(6):633-7.
21. Grewal S, Ali S, McConnell DW, Vandermeer B, Klassen TP. A randomized trial of nebulised 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med. 2009;163(11):1007-12.
22. Florin TA, Shaw KN, Kittick M, Yaskscoe S, Zorc JJ. Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial. 1. JAMA Pediatr. 2014;168(7):664-702.
23. Teunissen J, Hochs AH, Vaessen-Verberne A, Boehmer AL, Smeets CC, Brackel H, et al. The effect of 3 and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J. 2014;44(4):913-21.
24. Wu S, Baker C, Lang ME. Nebulized hypertonic saline for bronchiolitis: a randomized controlled trial. JAMA Pediatr. 2014;168(7):657-63.
25. Jacobs J, Foster M, Wan J, Pershad J. 7% hypertonic saline in acute bronchiolitis: a randomized controlled trial. Pediatrics. 2014;133:e8.
26. Wang EE, Milner R, Allen U, Maj H. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child. 1992;67:289-93.
27. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774-93.
28. Saghaei M. Random allocation software for parallel group randomised trials. BMC Med Res Methodol. 2004;4:26.
29. Schultz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMJ. 2010;340:c332.
30. Ralston S, Hill V, Martinez M. Nebulised hypertonic saline without adjunctive bronchodilators for children with bronchiolitis. Pediatrics. 2010;126:e520-5.